Pacific Edge - Latest News [Page 2]

Official Launch of Cxbladder Monitor in the USA

Tuesday, 13 December 2016, 5:06 pm | Pacific Edge

Cancer diagnostics company, Pacific Edge Limited (NZX:PEB) has commenced the official USA launch of its third bladder cancer diagnostic test, Cxbladder Monitor. More >>

Paper to Be Published in Prestigious Journal of Urology

Thursday, 8 December 2016, 2:15 pm | Pacific Edge

The prestigious American Journal of Urology has accepted for publication a paper confirming the superior performance of Pacific Edge’s Cxbladder Monitor test for the surveillance of bladder cancer recurrence, offering patients with bladder cancer ... More >>

Pacific Edge Named in Tin100 Top 10 List

Thursday, 20 October 2016, 12:33 pm | Pacific Edge

The growing success of cancer diagnostics company Pacific Edge has once again been recognised with company named in the 2016 TIN100 Top Ten list of Hot Emerging Companies for the second year in a row. More >>

Private Insurance Coverage Confirmed for Cxbladder

Thursday, 22 September 2016, 5:20 pm | Pacific Edge

Cancer diagnostics company, Pacific Edge (NZX:PEB) has advised that its Cxbladder diagnostics tests have been approved for reimbursement by a second major health insurance provider, nib Health Insurance in New Zealand. More >>

Chris Gallaher Elected New Chairman for Pacific Edge Board

Thursday, 25 August 2016, 3:33 pm | Pacific Edge

The Board of cancer diagnostics company, Pacific Edge Limited (NZX: PEB) has announced the election of Mr Chris Gallaher as Chairman, replacing Mr Chris Swann who, as previously advised, is stepping down from the Board at today’s Annual Shareholders’ Meeting. More >>

Pacific Edge Reports Another Year of Commercial Progress

Thursday, 26 May 2016, 11:08 am | Pacific Edge

Cancer diagnostics company Pacific Edge Limited (NZX: PEB) has reported another year of commercial progress and growth as it continues to gain traction for its bladder cancer diagnostic products in the United States and other targeted markets. More >>

Confirmation of Director Appointment

Tuesday, 5 April 2016, 12:53 pm | Pacific Edge

Pacific Edge Limited (PEB:NZX) has today advised that David Levison’s appointment as a Director has been confirmed, effective as at 2 April 2016. More >>

Pacific Edge Announces New Commercial Partnership

Wednesday, 17 February 2016, 11:27 am | Pacific Edge

Cancer diagnostics company, Pacific Edge Limited (NZX:PEB) has announced a new commercial partnership with Tolmar Australia Pty Limited, a specialised uro-oncology company which provides medicine and support to men with advanced prostate cancer. More >>

Pacific Edge Named in TIN100 Top 10 List

Thursday, 10 September 2015, 3:27 pm | Pacific Edge

Pacific Edge’s global growth and positive revenue trajectory has been recognised with the cancer diagnostics company named number 5 in the TIN100 Top Ten list of Hot Emerging Companies for 2015. More >>

Pacific Edge’s Cxbladder Detect Outperforms Other Diagnostic

Monday, 25 May 2015, 12:12 pm | Pacific Edge

Dunedin, NZ and Hershey, PA (May 25, 2015): Newly published research demonstrates that Cxbladder out performs other non-invasive bladder cancer diagnostics, announced Pacific Edge, Ltd. The new research comparing and ranking four widely used tests ... More >>

Pacific Edge’s half year report

Thursday, 18 December 2014, 1:56 pm | Pacific Edge

• Signed Cxbaldder agreement with Multiplan, a large National Provider Network (NPN) in the US. This is the fourth agreement to be signed with NPNs since October 2013. More >>

Pacific Edge launches Cxbladder Triage

Monday, 8 December 2014, 2:23 pm | Pacific Edge

Dunedin-based Pacific Edge has released today the second product in its suite of diagnostic tests for the detection and management of bladder cancer. More >>

Pacific Edge Reports Commercial Progress and Revenue Growth

Friday, 28 November 2014, 12:43 pm | Pacific Edge

Pacific Edge Limited (NZX: PEB) has today announced its interim results for the six months to 30 September 2014, with strong revenue growth reflecting the Company’s positive commercial progress following the launch of its revolutionary bladder cancer ... More >>

Europe patent for colorectal cancer prognostic technology

Wednesday, 26 November 2014, 1:35 pm | Pacific Edge

The European Intellectual Property Office which operates across 38 countries including all European Union members, has awarded Pacific Edge a patent for its colorectal cancer prognostic technology. More >>

Correction on Pacific Edge Limited Patent Issue

Wednesday, 26 November 2014, 1:34 pm | Pacific Edge

Pacific Edge Limited ("the Company") advises the market that it has incorrectly posted the NZX release for the issue of its bladder cancer patent in Europe. More >>

Pacific Edge announces appointment of CFO

Thursday, 13 November 2014, 3:36 pm | Pacific Edge

Pacific Edge is pleased to announce the appointment of Kate Rankin as Chief Financial Officer with effect from 17 November 2014. More >>

Pacific Edge Appoints Charles Sitch as Independent Director

Friday, 19 September 2014, 4:10 pm | Pacific Edge

Pacific Edge is pleased to announce the appointment of Charles Sitch as an Independent Director. More >>

US grants Pacific Edge patent for melanoma detection

Thursday, 4 September 2014, 2:20 pm | Pacific Edge

The United States Patent Office has granted Pacific Edge patent protection for 'Prognosis Prediction for Melanoma'. The patent covers the technology being used to develop the melanoma prognostic test that will enable clinicians to distinguish aggressive ... More >>

Kaiser Permanente signs up for Cxbladder

Wednesday, 27 August 2014, 12:05 pm | Pacific Edge

Pacific Edge Ltd has signed an agreement with Southern California Permanente Medical Group (SCPMG) to research its User Program to evaluate its bladder cancer technology Cxbladder within the clinical settings of Kaiser Permanente’s health care network. More >>

Pacific Edge AGM addresses

Friday, 22 August 2014, 5:05 pm | Pacific Edge

Chairman and CEO addresses to the Pacific Edge annual shareholders meeting held in Dunedin late Thursday afternoon. More >>